2HOUSE A A, ELIASZIW M, CATTRAN D C, et al. Effect of B vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial[J]. JAMA, 2010,303 ( 16 ) : 1603- 1609.
3KANTER M, SEN S, DONMEZ S, et al.Protective effects of irbesartan and alpha lipoic acid in STZ-in- duced diabetic nephropathy in rats[J]. Ren Fail, 2010,32(4): 498-505.
4MIN D, LYONS J G, BONNER J, et al. Mesangial cell-de- rived factors alter monoeyte activation and function through in- flammatory pathways: possible pathogenic role in diabetic ne phropathy[J], Am J Physiol Renal Physiol , 2009,297(5) : F1229-1237.
5HASSLACHER C, COLLENBERG E, MOCKS J. Effect of insulin analogs on the decline of hemoglobin in diabetic patients with nephropathy[J]. Exp Clin Endocrinol Diabetes, 2010, 118(6) :341-345.
6MULAY S R, GAIKWAD A B, TIKOO K. Combination of aspirin with telmisartan suppresses the augmented TGFbeta/ smad signaling during the development of streptozotocin in duced type I diabetic nephropathy[J]. Chem Biol Interact, 2010,85(2) :137-142.
7OWCZAREK D, CIBOR D, MACH T. Asymmetric dimethy- larginine ( ADMA), symmetric dimethylarginine ( SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases[J]. In flamm Bowel Dis, 2010,6(1) :52-57.
8DIMOPOULOS N, PIPERI C, PSARRA V, et al. Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression[J]. Psychiatry Res, 2008, 161 (1) : 59-66.
9SAENGER A K, LAHA T J, EDENFIELD M J, et al. Quan- tification of urinary 8-iso-PGF2alpha using liquid chromatogra phy-tandem mass spectrometry and association with elevated troponin levels [J]. Clin Biochem, 2007, 40 ( 16 17 ) : 1297- 1304.
10TSIKAS D. Handling of commercially available enzyme immu noassays for 8 iso-prostaglandin F2alpha (8-iso-PGF2alpha, iPF2alpha-Ⅲ, 15-F2t-IsoP) in clinical research and science: considerations from the analytical and review point of view[J]. Clin Chim Acta, 2004, 344(1/2) :215-217.
8Dallinger KJ,Jenning PE,Toop MJ.Platelet aggregation and coagulation factors in insulin dependent diabetes with and with out microangiography[J].Diabetes Med,2010,39(3):340-344.
9Vague P,Juhanl.Red cell deformability,platelet aggregation and insulin action[J].Diabetes,2011,41(12):317-325.
10Yamazzki Y,Knwamum K,Yasuda H.Inhibitory effect of cilostazol on carotid hypertrophy in DM patients[J].Yakuri to Chiryo,2010,21(11):483-489.
